Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder

• Qiusui Mai,
• Bailin He,
• Shikai Deng,
• Qing Zeng,
• Yanwen Xu,
• Cong Wang,
• Yunyi Pang,
• Sheng Zhang,
• Jinfeng Li,
• Jinfeng Zeng,
• Liqin Huang,
• Yongshui Fu,
• Chengyao Li,
• Tingting Li,
• Xiaojun Xu,
• Ling Zhang

Affiliations

Qiusui Mai

Department of Blood Transfusion, The Seventh Affiliated Hospital, Sun Yat-Sen University

Bailin He

Department of Hematology, Nanfang Hospital, Southern Medical University

Shikai Deng

Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University

Qing Zeng

Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University

Yanwen Xu

Department of Obstetrics, He Xian Memorial Affiliated Hospital of Southern Medical University

Cong Wang

Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University

Yunyi Pang

Department of Obstetrics, Nanfang Hospital, Southern Medical University

Sheng Zhang

Shenzhen Bao’an District Central Blood Station

Jinfeng Li

Shenzhen Bao’an District Central Blood Station

Jinfeng Zeng

Shenzhen Blood Center

Liqin Huang

Shenzhen Blood Center

Yongshui Fu

Guangzhou Blood Center

Chengyao Li

Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University

Tingting Li

Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University

Xiaojun Xu

Department of Blood Transfusion, The Seventh Affiliated Hospital, Sun Yat-Sen University

Ling Zhang

Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University